Survival in BRAF-mutant metastatic melanoma in the real-world setting: results from the Dutch Melanoma Treatment Registry

被引:0
|
作者
Schouwenburg, M. [1 ]
Jochems, A. [1 ]
Aarts, M. [2 ]
van den Berkmortel, F. [3 ]
van den Eertwegh, A. [4 ]
Franken, M. [5 ]
Groenewegen, G. [6 ]
de Groot, J-W. [7 ]
Haanen, J. B. A. G. [8 ]
Hospers, G. [9 ]
Kapiteijn, E. [10 ]
Koornstra, R. [11 ]
Kruit, W. [12 ]
Louwman, M. [13 ]
Piersma, D. [14 ]
van Rijn, R. [15 ]
Ten Tije, A. J. [16 ]
Vreugdenhil, G. [17 ]
Wouters, M. [18 ]
van der Hoeven, J. [1 ]
机构
[1] LUMC, Med Oncol, Leiden, Netherlands
[2] MUMC, Med Oncol, Maastricht, Netherlands
[3] Atrium Med Ctr Parkstad, Med Oncol, Heerlen, Netherlands
[4] Vrije Univ Amsterdam Med Ctr, Med Oncol, Amsterdam, Netherlands
[5] Erasmus Univ, Inst Med Technol Assessment, Med Technol Assessment, Rotterdam, Netherlands
[6] Univ Med Ctr Utrecht, Med Oncol, Utrecht, Netherlands
[7] Isala Klin, Med Oncol, Zwolle, Netherlands
[8] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[9] Univ Hosp Groningen UMCG, Med Oncol, Groningen, Netherlands
[10] LUMC, Clin Oncol, Leiden, Netherlands
[11] Radboud Univ Nijmegen, Med Ctr Nijmegen, Med Oncol, Nijmegen, Netherlands
[12] Erasmus MC, Internal Oncol, Daniel den Hoed Canc Ctr, Rotterdam, Netherlands
[13] Netherlands Comprehens Canc Org IKNL, Epidemiol, Utrecht, Netherlands
[14] MST, Med Oncol, Enschede, Netherlands
[15] Med Ctr Leeuwarden, Med Oncol, Leeuwarden, Netherlands
[16] Amphia Ziekenhuis, Med Oncol, Breda, Netherlands
[17] Maxima Med Ctr, Med Oncol, Eindhoven, Netherlands
[18] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Surg Oncol, Amsterdam, Netherlands
关键词
D O I
10.1093/annonc/mdw379.34
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1139P
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Survival and Early FDG PET Response to BRAF and MEK Inhibition in Patients with BRAF-mutant Melanoma
    Schmitt, Ronald
    Kreidler, Sarah
    Glueck, Deborah
    Amaria, Rodabe
    Gonzalez, Rene
    Lewis, Karl
    Bagrosky, Brian
    Kwak, Jennifer
    Koo, Phillip
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [32] Treatment Reality of Patients with BRAF-Mutant Advanced/Metastatic Melanoma in Germany, Austria and Switzerland in the Era of Choice
    Haferkamp, Sebastian
    Wolf, Ingrid
    Alter, Mareike
    Debus, Dirk
    Schilling, Bastian
    Hunger, Robert
    Terheyden, Patrick
    Gerard, Camille Lea
    Zihler, Deborah
    Pinter, Andreas
    Utikarl, Jochen
    Sachse, M.
    Haalck, Thomas
    Zechariah, Ralph
    Mangana, Johanna
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 177 - 177
  • [33] Real-world treatment patterns and outcomes in patients with metastatic melanoma
    Dokanovic, Dejan
    Lazic, Bojana
    Gojkovic, Zdenka
    Cvijetic, Zeljka
    Sokolovic, Emir
    Ceric, Timur
    Jungic, Sasa
    [J]. SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2023, 151 (3-4) : 209 - 215
  • [34] Efficacy of encorafenib/binimetinib in patients with metastatic melanoma with brain metastases: Results from the nationwide Dutch Melanoma Treatment Registry
    Bloem, Manja
    van Not, Olivier Jules
    Aarts, Maureen J. B.
    Van den Berkmortel, Franchette
    Blank, Christian U.
    Blokx, Willeke
    Boers-Sonderen, Marye J.
    Bonenkamp, Han J.
    de Groot, Jan Willem
    Haanen, John
    Hospers, Geke
    Kapiteijn, Ellen
    Piersma, Djura
    van Rijn, Rozemarijn
    Stevense-den Boer, Marion
    Van der Veldt, Astrid Aplonia Maria
    Vreugdenhil, Gerard
    Wouters, Michel W. J. M.
    Suijkerbuijk, Karijn
    Van den Eertwegh, Alfonsus Johannes Maria
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] The real-world impact of modern treatments on the survival of patients with metastatic melanoma
    Donia, Marco
    Ellebaek, Eva
    Ollegaard, Trine Heide
    Duval, Lone
    Aaby, Jens Bull
    Hoejberg, Lise
    Kohler, Ulrich Heide
    Schmidt, Henrik
    Bastholt, Lars
    Svane, Inge Marie
    [J]. EUROPEAN JOURNAL OF CANCER, 2019, 108 : 25 - 32
  • [36] The real-world impact of cancer immunotherapy on the survival of patients with metastatic melanoma
    Donia, M.
    Ellebaek, E.
    Oellegaard, T. H.
    Duval, L.
    Aaby, J. B.
    Hoejberg, L.
    Koehler, U. H.
    Schmidt, H.
    Bastholt, L.
    Svane, I-M.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [37] The real-world impact of modern treatments on the survival of patients with metastatic melanoma
    Donia, M.
    Ellebaek, E.
    Ollegaard, T. H.
    Duval, L.
    Aaby, J. B.
    Hojberg, L.
    Kohler, U. H.
    Schmidt, H.
    Bastholt, L.
    Svane, I-M.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [38] BRAF-Mutant Metastatic Melanoma Presenting as a Fungating Soft Tissue Mass Suspicious for Sarcoma
    Chen, Stephen
    Lee, Stella J.
    [J]. OPERATIVE TECHNIQUES IN ORTHOPAEDICS, 2020, 30 (02)
  • [39] Melanoma Targeted Therapies beyond BRAF-Mutant Melanoma: Potential Druggable Mutations and Novel Treatment Approaches
    Khaddour, Karam
    Maahs, Lucas
    Avila-Rodriguez, Ana Maria
    Maamar, Yazan
    Samaan, Sami
    Ansstas, George
    [J]. CANCERS, 2021, 13 (22)
  • [40] QUALITY OF LIFE IN ADVANCED MELANOMA: RESULTS OF THE DUTCH MELANOMA TREATMENT REGISTRY
    Franken, M.
    Leeneman, B.
    Schouwenburg, M.
    Jochems, A.
    Aarts, M.
    van Akkooi, A.
    van den Berkmortel, F.
    van, den Eertwegh A.
    Groenewegen, G.
    de Groot, J.
    Haanen, J.
    Hospers, G.
    Kapiteijn, E.
    Koornstra, R.
    Kruit, W.
    Louwman, M.
    Piersma, D.
    van Rijn, R.
    ten Tije, A.
    Vreugdenhil, G.
    Wouters, M.
    van Zeijl, M.
    van der Hoeven, J.
    Uyl-de Groot, C.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A747 - A747